WORK GROUP CLINICAL

The goal of the Clinical WG is to translate clinical insight on liquid biopsy applications into clinical utility.

This is achieved by:

• Identification of urgent clinical needs (markers and assays)
  
• Identification of relevant projects from clinical perspective
  
• Providing guidance and clinical perspective for the other WGs
  
• Defining good practice criteria for inclusion of LB in clinical trials
  
• Revising and designing “ELBS approved” clinical trials in the realm of LB
  
  

Leads: Claus Lindbjerg Andersen, Jean-Yves Pierga, Nikolas von Bubnoff, Christoffer Gebhardt